Michel Sadelain, MD, PhD
Disclosures: Co-founder, Juno Therapeutics. Collaborative research agreements-Juno Therapeutics, Fate, Atarabio, Takeda|Royalty-Juno Therapeutics, Takeda|Scientific Advisory Board-Berkeley Lights
No Bio Available.